USA |NASDAQ |USD |ADR
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 21, 2022 | Dec 2021 | $0.12 | - | $-0.29 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 21, 2022 | Dec 2021 | $39.48M | - | $944.00K |
Ac Immune Sa's next earnings date is Monday, Mar 21, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $0.12 | $-0.33 | $0.93 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $-0.43 | $-1.16 | $0.11 |
| Dec 2022 | 3 | $0.09 | $-0.01 | $0.19 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $0.12 | $0.11 | $0.27 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.43 | $-0.41 | $-0.51 |
| Dec 2022 | 0 / 0 | $0.09 | $0.10 | $-0.10 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $39.48M | $1.53M | $88.41M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $42.68M | $3.05M | $89.23M |
| Dec 2022 | 3 | $77.03M | $26.79M | $109.63M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 11, 2021 | Sep 2021 | $-0.30 | - | - |
| Aug 4, 2021 | Jun 2021 | $-0.23 | $-0.29 | -25.72% |
| Apr 28, 2021 | Mar 2021 | $-0.24 | $-0.25 | -3.35% |
| Mar 23, 2021 | Dec 2020 | $-0.27 | $-0.29 | -8.20% |
| Nov 13, 2020 | Sep 2020 | $-0.27 | $-0.28 | -6.03% |
| Aug 5, 2020 | Jun 2020 | $-0.29 | $-0.24 | 15.91% |
| May 4, 2020 | Mar 2020 | $-0.14 | $-0.11 | 21.29% |
| Mar 30, 2020 | Dec 2019 | $-0.22 | $-0.29 | -30.21% |
| Nov 13, 2019 | Sep 2019 | $-0.05 | $0.25 | 634.25% |
| Aug 14, 2019 | Jun 2019 | $-0.23 | $-0.25 | -7.83% |
| May 15, 2019 | Mar 2019 | $1.33 | $0.90 | -32.32% |
| Mar 21, 2019 | Dec 2018 | $0.35 | $-0.21 | -161.06% |
| Nov 13, 2018 | Sep 2018 | $-0.22 | $-0.21 | 6.00% |
| Aug 8, 2018 | Jun 2018 | $-0.23 | $-0.19 | 15.39% |
| May 2, 2018 | Mar 2018 | $-0.20 | $-0.20 | 1.62% |
| Mar 20, 2018 | Dec 2017 | $0.02 | $0.08 | 314.36% |
| Nov 13, 2017 | Sep 2017 | $-0.13 | $-0.15 | -16.83% |
| Aug 9, 2017 | Jun 2017 | $-0.16 | $-0.23 | -38.78% |
| May 11, 2017 | Mar 2017 | $-0.17 | $-0.17 | -1.32% |
| Mar 17, 2017 | Dec 2016 | $-0.15 | $-0.09 | 41.24% |
| Nov 11, 2016 | Sep 2016 | $-0.17 | $-0.18 | -8.16% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 23, 2021 | Dec 2020 | $-0.89 | $-0.93 | - |
| Mar 30, 2020 | Dec 2019 | $0.69 | $0.62 | -10.70% |
| Mar 21, 2019 | Dec 2018 | $-0.21 | $-0.81 | - |
| Mar 20, 2018 | Dec 2017 | $-0.59 | $-0.46 | - |
| Mar 17, 2017 | Dec 2016 | - | $-0.27 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 11, 2021 | Sep 2021 | $1.93M | - | - |
| Aug 4, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| Apr 28, 2021 | Mar 2021 | $3.64M | $0.00 | - |
| Mar 23, 2021 | Dec 2020 | $1.40M | $944.00K | 0.67% |
| Nov 13, 2020 | Sep 2020 | $930.00K | $1.12M | 1.21% |
| Aug 5, 2020 | Jun 2020 | $550.00K | $1.28M | 2.32% |
| May 4, 2020 | Mar 2020 | $13.31M | $12.41M | 0.93% |
| Mar 30, 2020 | Dec 2019 | $11.26M | $1.06M | 0.09% |
| Nov 13, 2019 | Sep 2019 | $31.43M | $33.41M | 1.06% |
| Aug 14, 2019 | Jun 2019 | $1.20M | $1.51M | 1.26% |
| May 15, 2019 | Mar 2019 | $97.25M | $75.04M | 0.77% |
| Mar 21, 2019 | Dec 2018 | $43.27M | $1.40M | 0.03% |
| Nov 13, 2018 | Sep 2018 | $850.00K | $2.31M | 2.71% |
| Aug 8, 2018 | Jun 2018 | $950.00K | $2.03M | 2.14% |
| May 2, 2018 | Mar 2018 | $2.12M | $1.46M | 0.69% |
| Mar 20, 2018 | Dec 2017 | $14.81M | $16.42M | 1.11% |
| Nov 13, 2017 | Sep 2017 | $7.81M | $1.07M | 0.14% |
| Aug 9, 2017 | Jun 2017 | $4.29M | $750.00K | 0.17% |
| May 11, 2017 | Mar 2017 | - | $2.01M | - |
| Mar 17, 2017 | Dec 2016 | - | $1.43M | - |
| Nov 11, 2016 | Sep 2016 | - | $1.33M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 23, 2021 | Dec 2020 | $16.81M | $15.43M | -8.20% |
| Mar 30, 2020 | Dec 2019 | $111.71M | $111.03M | -0.61% |
| Mar 21, 2019 | Dec 2018 | $49.08M | $7.19M | -85.34% |
| Mar 20, 2018 | Dec 2017 | $18.92M | $20.25M | 7.06% |
| Mar 17, 2017 | Dec 2016 | - | $23.21M | - |
ACIU's next earnings date is Monday, Mar 21, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Ac Immune Sa's next quarterly earnings is $0.12, with a low EPS estimation of $-0.33, and a high estimation of $0.93.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.12, the last 2 month trend is $0.11, and the 3 month trend is $0.27.
Based on analysts, the average revenue estimation is $39.48M, with a low revenue estimation of $1.53M, and a high estimation of $88.41M.
Ac Immune Sa's previous earnings date was Nov 11, 2021 for its fiscal quarter ended Sep 30, 2021.
Ac Immune Sa's previous annual earnings date was Mar 23, 2021 for its fiscal year ended Dec 31, 2020.
ACIU's earnings per share (EPS) was $-0.93, missing the consensus analysts forecast of $-0.89 by 4.47% , and lower than the previous year's EPS (Dec 2019) by -250.89%.
Revenues were $15.43M, worse than the forecast of $16.81M by -8.20%, and down by -86.10% from previous year's revenue.
The company reported a net income of $-61.92M.
Ac Immune Sa reported a free cash flow of $-61.22M for its fiscal year, compared to $53.34M a year ago.
The company ended the fiscal year with $2.22M in total debt, a decrease of -23.53% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
